Charles B. Foster

Variant genotypes of the low-affinity Fcgamma receptors in two control populations and a review of low-affinity Fcgamma receptor polymorphisms in control and disease populations.

K. Huppi, L. Goldin, S. Leitman, 1999, Blood.

An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus.

S. Steinberg, S. Chanock, J. Metcalf, 2000, Blood.

Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease.

S. Chanock, D. Venzon, C. Foster, 1998, The Journal of clinical investigation.

Polymorphisms in the IL‐1 receptor antagonist gene VNTR are possible risk factors for juvenile idiopathic inflammatory myopathies

S. Jimenez, C. Foster, F. Miller, 2000, Clinical and experimental immunology.